Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, AutologousTransplantation, HomologousTransplantation ConditioningGraft vs Host DiseaseHematopoietic Stem Cell MobilizationHematologic NeoplasmsStem Cell TransplantationGraft SurvivalBone MarrowGranulocyte Colony-Stimulating FactorLeukapheresisTissue DonorsTreatment OutcomeMelphalanCombined Modality TherapyAntigens, CD34CyclophosphamideBusulfanHistocompatibilityHematopoietic Stem CellsTransplantation ChimeraBlood Component RemovalBone Marrow CellsHistocompatibility TestingRecurrenceWhole-Body IrradiationCord Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaStem CellsMyeloablative AgonistsLiver TransplantationRemission InductionLeukemiaLymphoma, Non-HodgkinRetrospective StudiesTransplantation, IsogeneicAnemia, AplasticEtoposideSurvival AnalysisHematopoiesisImmunosuppressive AgentsAntineoplastic Agents, AlkylatingTime FactorsSurvival RateKidney TransplantationDisease-Free SurvivalThiotepaLeukemia, Myeloid, AcuteInfectionHLA AntigensBone Marrow PurgingPOEMS SyndromeCarmustineLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Leukemia EffectCytarabineSalvage TherapyFollow-Up StudiesVidarabineMyelodysplastic SyndromesIslets of Langerhans TransplantationHodgkin DiseaseBlood CellsVincristineLymphocyte DepletionBone Marrow DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaCytomegalovirus InfectionsPlatelet CountGraft RejectionAmyloidosisDonor SelectionLymphomaImmunosuppressionIfosfamideHematologic DiseasesCyclosporineBone and BonesFatal OutcomeBlood Cell CountTransplantation ImmunologyOpportunistic InfectionsAcute DiseaseNeoplasmsImmunophenotypingProspective StudiesT-LymphocytesHistiocytosis, Non-Langerhans-CellPrognosisLeukocyte CountLymphocyte TransfusionLeukocyte TransfusionFeasibility StudiesGraft vs Tumor EffectNuclear FamilyRecombinant Proteins